| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 15 Oct 25 | VRTX Vertex Pharmaceuticals | Deferred Stock Units Common Stock | Grant | Acquire A | No | No | 410.31 | 115.766 | 47.50 k | 15,457.433 |
| 6 Aug 25 | VRTX Vertex Pharmaceuticals | Common Stock | Buy | Acquire P | No | No | 389.84 | 3,366 | 1.31 mm | 45,000 |
| 6 Aug 25 | VRTX Vertex Pharmaceuticals | Common Stock | Buy | Acquire P | No | No | 389.36 | 1,634 | 636.21 k | 41,634 |
| 15 Jul 25 | VRTX Vertex Pharmaceuticals | Deferred Stock Units Common Stock | Grant | Acquire A | No | No | 469.34 | 101.206 | 47.50 k | 15,341.667 |
| 1 May 25 | VRTX Vertex Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 502.97 | 2,398 | 1.21 mm | 2,398 |
| 15 Apr 25 | VRTX Vertex Pharmaceuticals | Deferred Stock Units Common Stock | Grant | Acquire A | No | No | 497.51 | 95.475 | 47.50 k | 15,240.461 |